EPO Newsletter

Newsletter archive

Newsletter March 2021

Tumor Model Insights 03/2021: Partially temozolomide resistant, IDH-wildtype glioblastoma PDX model (Glio10618)


Subscribe to the EPO newsletter

Your registration could not be saved. Please try again.
Your registration was successful.

Stay updated and subscribe to our newsletter! 

We use Sendinblue as our marketing platform. By Clicking below to submit this form, you acknowledge that the information you provided will be transferred to Sendinblue for processing in accordance with their terms of use.